Is Abilify Used for MDI
Links shared publicly online about this topic
Treat Schizophrenia and Bipolar Disorder With Abilify
health.ezinemark.com — “Typically Abilify is a medication that you can avail of only with a doctor's prescription to treat diseases like schizophrenia and bipolar disorder and in recent years it has also been found effective to treat the irritation that arises in autistic patients. It is also used in the treatment of major depression in combination w8ith an antidepressant medication and this is termed augmentation.” View full resource at health.ezinemark.com
Most Recently Shared on September 21, 2010 at 1:59 pm By:
Peter H Brown Doctor and Psychologist
Treat Schizophrenia and Bipolar Disorder With Abilify http://bit.ly/dD3SW5 #bipolar
Abilify Study Flawed, Say Researchers - Is Long-Term Use Appropriate?
bipolar.about.com — “A newly published study says that having a bipolar parent increases the everyday level of a key stress hormone. This might seem like a no-brainer, but in fact” View full resource at bipolar.about.com
Most Recently Shared on May 10, 2011 at 6:54 am By:
Peter H Brown Doctor and Psychologist
Abilify Study Flawed, Say Researchers - Is Long-Term Use Appropriate? http://bit.ly/k7TXET #bipolar
Evidence For Abilify & Bipolar Disorder Is Debated // Pharmalot
pharmalot.com — “Evidence For Abilify & Bipolar Disorder Is Debated // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on May 4, 2011 at 3:08 pm By:
Peter H Brown Doctor and Psychologist
Evidence For Abilify & Bipolar Disorder Is Debated // Pharmalot http://bit.ly/jjRuKs #bipolar
Bipolar Treatment Abilify Questioned For Long-Term Use | ThirdAge
thirdage.com — “The bipolar treatment drug Abilify could potentially be keeping doctors from prescribing more established drugs, a new review suggests.” View full resource at thirdage.com
Most Recently Shared on May 5, 2011 at 9:23 pm By:
Peter H Brown Doctor and Psychologist
Bipolar Treatment Abilify Questioned For Long-Term Use http://bit.ly/kFnxeu #bipolar
Bipolar-disorder Related Drugs, Abilify, Quetiapine - Drugs - EverydayHealth.com
everydayhealth.com — “Find information on prescription and OTC drugs that treat Bipolar-disorder like Abilify, Abilify Discmelt, Aripiprazole, Calan, Calan SR, Carbamazepine, Carbatrol, Catapres, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3. Find medical information on side effects, drug interactions, dosage, and user ratings and reviews.” View full resource at everydayhealth.com
Most Recently Shared on April 8, 2010 at 3:09 am By:
Peter H Brown Doctor and Psychologist
Bipolar-disorder Related Drugs, Abilify, Quetiapine ... http://bit.ly/b62GaM #bipolar
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripiprazole), Europe
medicalnewstoday.com — “The european medicines agency has been formally notified by otsuka pharmaceutical europe ltd of its decision to withdraw its application for an extension of indication for the centrally authorised” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2009 at 11:41 am By:
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripipra.. http://bit.ly/1QCH4R
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Drugs and Devices OW OW Health
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
First-Line Use of Abilify Has More Than Doubled Over the Past Year... -- BURLINGTON, Mass., Nov. 16, 2010 /PRNewswire/ --
prnewswire.com — “First-Line Use of Abilify Has More Than Doubled Over the Past Year for the Treatment of Newly-Diagnosed Patients in Bipolar Disorder. Physicians Expect Use of Seroquel XR and Abilify to Increase Over the Next Two Years, According to a New Report from Decision Resources.” View full resource at prnewswire.com
Most Recently Shared on November 16, 2010 at 8:05 pm By:
Peter H Brown Doctor and Psychologist
First-Line Use of Abilify Has More Than Doubled Over the Past Year for the ... http://bit.ly/cjxrZt #bipolar
U.S. Food and Drug Administration Approves Abilify (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
drugs.com — “Abilify (aripiprazole) is used to treat irritability associated with autistic disorder in pediatric patients. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 24, 2009 at 12:10 am By:
FDA Approves Abilify for Irritability Associated with Autistic Disorder in Pediatric Patients - http://bit.ly/62jJ8P
FDA panel recommends change to label of Abilify - Related Stories - AAP SmartBrief
smartbrief.com — “An FDA panel unanimously concluded that the label of Bristol-Myers Squibb's antipsychotic Abilify for use in children lacks information on the risk of excessive weight gain. The panel advised Bristol-Myers to keep monitoring pediatric use of the drug and move data on its metabolic effect on children” View full resource at smartbrief.com
Most Recently Shared on December 11, 2009 at 6:07 am By:
Clara Song Doctor, Pediatrician, and Physician
FDA panel recommends change to label of Abilify http://sbne.ws/r/3qaF
News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health
reuters.com — “News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health” View full resource at reuters.com
Most Recently Shared on September 10, 2010 at 3:45 am By:
Hisham Rana, MD Doctor and Physician
News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health
First-line use of Abilify more than doubles over past year for newly-diagnosed patients with bipolar disorder - Pharmaceutical and Biotechnology News - Pharma Letter
thepharmaletter.com — “First-line use of Bristol Myers-Squibb(NYSE: BMY)/Otsuka's (TYO: 4523) Abilify (aripiprazole) has increased over the past year in newly-diagnosed patients from 4.1% patient share to 8.8%, according to Treatment Algorithms in Bipolar Disorder from advisory” View full resource at thepharmaletter.com
Most Recently Shared on November 19, 2010 at 12:18 pm By:
Peter H Brown Doctor and Psychologist
First-line use of Abilify more than doubles over past year for newly-diagnosed ... http://bit.ly/bEbbvc #bipolar
A drug used for maintenance treatment of bipolar disorder lacks evidence, scientists contend - latimes.com
latimes.com — “Only one badly flawed study was used to support the approval of Abilify (aripiprazole) for the maintenance treatment of bipolar disorder, scientists contend in an analysis of the data” View full resource at latimes.com
Most Recently Shared on May 4, 2011 at 10:25 am By:
Timothy Lomauro Doctor, Psychologist, and PhD
A drug used for maintenance treatment of #bipolar disorder lacks evidence, scientists contend - latimes.com http://t.co/gf4DcOb #psych
Long-Term Use of Bipolar Drug Questioned - Health News - Health.com
news.health.com — “The growing use of a popular drug in the long-term treatment of bipolar disorder is based largely on a single, flawed clinical trial that may be steering doctors and patients away from drugs with a more established track record, a new review suggests.” View full resource at news.health.com
Most Recently Shared on May 4, 2011 at 1:54 pm By:
Peter H Brown Doctor and Psychologist
Long-Term Use of Bipolar Drug Questioned - Health News - Health.com http://bit.ly/jDWmI2 #bipolar
Pervasive Developmental Disorder: eMedicine Pediatrics: Developmental and Behavioral
emedicine.medscape.com — “Overview: Pervasive developmental disorders (PDDs) include a spectrum of behavioral problems commonly associated with autism. The Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) includes autistic disorder, Rett syndrome, childhood disintegrative disorder, Asperger's disorder, and ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 16, 2010 at 8:21 pm By:
Medscape Pediatrics Pediatrics and Health Site
Abilify now FDA approved for use in child autism. See the eMedicine article Pervasive Developmental Disorder. http://bit.ly/bmalwP
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
Advertisement
